NZ Rheumatology Research Review Issue 34

In this issue:

60% risk of nephrolithiasis in gout patients
Long-term liver safety data with tocilizumab in RA
Disease activity-guided TNFi dose reduction in RA
Is chondroitin sulfate beneficial in knee OA?
Long-term data support the benefit of GCs in early RA
Tocilizumab beneficial in giant cell arteritis
Guided graded exercise self-help improves CFS
Oral tofacitinib: a new treatment option in RA
Support for escalation of DMARD combinations before biologics
More QALYs with triple therapy vs TNFi/MTX

Please login below to download this issue (PDF)